- Lobbying
- Melissa AND Francis
Lobbying Arrangements Results for 'Melissa Francis'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Health care funding and appropriations |
Roper Saint Francis Foundation
|
STRATEGIC HEALTH CARE | |||
Details Pass through and small business tax issues. |
S CORPORATION ASSOCIATION
|
VENN STRATEGIES | |||
Details R&D tax issues, including HR 4549, The American Innovation and Competitiveness Act. |
Intel
|
VENN STRATEGIES, LLC | |||
Details Tax issues related to strengthening and expanding the Low-Income Housing Tax Credit and Tax-Exempt Housing Bonds (including HR 3238 and S1557). |
Affordable Housing Tax Credit Coalition
|
VENN STRATEGIES | |||
Details Regulation related to supplemental group benefits. Tax issues and regulation related to insurance, financial and retirement services and products and supplemental group benefits Financial services ... |
Securian Financial Group
|
VENN STRATEGIES | |||
Details Financial Services issues impacting fraternal benefit societies, including the Department of Labor Retirement Security proposed rule (RIN: 1210-AC02). Tax issues concerning fraternal benefit societ... |
THRIVENT FINANCIAL FOR LUTHERANS
|
VENN STRATEGIES | |||
Details Policies related to biopharmaceutical access and innovation. |
UCB, Inc.
|
VENN STRATEGIES | |||
Details Legislation and other proposed policy change impacting S Corporation ESOPs. |
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA
|
VENN STRATEGIES | |||
Details General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response. Measures related to U.S. international and corpor... |
Regeneron Pharmaceuticals, Inc.
|
VENN STRATEGIES | |||
Details Issues relating to: Anti Money Laundering; Beneficial Ownership; FinTech Policy, Data Breaches, Privacy Protection; Real Time payments; Industrial Loan Companies (ILCs); Charters. Paycheck Protecti... |
Bank Policy Institute
|
in-house lobbying | |||
Details Issues related to prescription-to- over the counter switch; issues related to influenza vaccines; issues related to 340B; issues related to Respiratory Syncytial Virus (RSV) access; issues related ... |
Sanofi US Services Inc.
|
in-house lobbying | |||
Details Hill outreach to oppose site-neutral payment cuts; Hill outreach in support of the Acute Hospital Care at Home program; Hill outreach about streamlining prior authorization in Medicare Advantage pl... |
American Hospital Association
|
in-house lobbying |